Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan-Reference-Cited by-同舟云学术

Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan

Published:2021-12-23 Issue: Volume: Page:
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Hara Azusa¹,Hara Kanae²,Komeda Takuji³,Ogura Eriko²,Miyazawa Shogo²,Kobayashi Chiduru²,Fujiwara Masakazu²,Yoshida Manami²,Urushihara Hisashi¹^ORCID

Affiliation:

1. Division of Drug Development and Regulatory Science, Faculty of Pharmacy Keio University Tokyo Japan

2. Shionogi & Co., Ltd. Osaka Japan

3. Shionogi Pharmacovigilance Center Co., Ltd. Osaka Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5392

Reference36 articles.

1. Japanese Surveillance Systems and Treatment for Influenza

2. The characteristics of influenza-like illness management in Japan

3. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia

4. Influenza-associated thrombotic microangiopathies

5. Increased incidence of subarachnoid hemorrhage during cold temperatures and influenza epidemics

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world disproportionality analysis of Baloxavir Marboxil: post-marketing pharmacovigilance data;Expert Opinion on Drug Safety;2024-09-05

2. Considerations when treating influenza infections with oseltamivir;Expert Opinion on Pharmacotherapy;2024-07-02

3. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04-24

4. Comparison of the incidence of severe outcomes in outpatients with COVID-19 or seasonal influenza without risk factors: Retrospective analysis of a health insurance claims-database;Journal of Clinical Virology Plus;2024-02

5. UPLC-Q-Exactive/MS based analysis explore the correlation between components variations and anti-influenza virus effect of four quantified extracts of Chaihu Guizhi decoction;Journal of Ethnopharmacology;2024-01